STOCK TITAN

Perimeter Medical Imaging AI Inc - PYNKF STOCK NEWS

Welcome to our dedicated news page for Perimeter Medical Imaging AI (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging AI.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Perimeter Medical Imaging AI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Perimeter Medical Imaging AI's position in the market.

Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. announces upcoming events and grant funding opportunities to support AI technology development. The company will showcase its Perimeter S-Series OCT technology at an international conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
earnings AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. announced positive results from a study on Wide Field Optical Coherence Tomography (WF-OCT) and AI technology in breast cancer surgery. The AI model showed high sensitivity and specificity, potentially reducing reoperation rates. Perimeter's CEO highlighted the AI's potential in improving surgical outcomes and expanding market reach. An ongoing clinical trial led by Dr. Alastair Thompson aims to evaluate Perimeter's technology further.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.01%
Tags
AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PYNKF) releases study results on reoperation rates after breast-conserving surgery, highlighting high costs and risks. The study emphasizes the need for improved margin assessment methods to reduce reoperation rates and complications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.29%
Tags
AI
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PYNKF) announced further commercial expansion within a major national healthcare system, with a follow-on placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas. The company's CEO stated that the expansion validates the value of the technology in cancer surgery and its potential benefits to patients. The S-Series OCT is a pioneering medical imaging system that provides real-time margin visualization of excised tissue specimens in the operating room at significantly higher image resolution than traditional imaging methods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.04%
Tags
AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PINK) announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas, part of a major national healthcare system. The S-Series OCT provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than MRI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (PINK) to Participate in Investor Webinar Discussing AI in Cancer Surgery with Dr. Amelia Tower
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
AI
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) announced the appointment of Adrian Mendes to its Board of Directors. The company reported financial results for Q3 2023, highlighting advancements in a grant funding program, positive interactions with the FDA, initiation of additional clinical trial sites, and the appointment of Adam Hodges as Vice President, Sales and Marketing. The CEO, Adrian Mendes, expressed satisfaction with the progress made, particularly in the development of next-gen AI tech for clinical trials, and the company's shortlisting for a grant funding program sponsored by ARPA-H under the Biden Cancer Moonshot Initiative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
earnings AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) will report its Q3 2023 financial and operating results on November 14, 2023, after the U.S. financial markets close. The conference call/webcast, featuring CEO Adrian Mendes, will provide insights into the company's performance and future prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
earnings AI
-
Rhea-AI Summary
Perimeter Medical Imaging AI, Inc. has announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center in Seattle, WA. The trial is evaluating the Perimeter B-Series OCT combined with its proprietary ImgAssist AI software for breast conservation surgeries. The company aims to improve patient outcomes and reduce healthcare costs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.89%
Tags
clinical trial AI
Rhea-AI Summary
Perimeter Medical Imaging AI will host an investor webcast on October 25, 2023, to provide an overview of key areas of the company's business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
conferences AI
Perimeter Medical Imaging AI Inc

OTC:PYNKF

PYNKF Rankings

PYNKF Stock Data

41.97M
33.49M
0.62%
25.36%
Dimension Stone Mining and Quarrying
Mining, Quarrying, and Oil and Gas Extraction
Link
Canada
Toronto